Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,213
Closed -$5.27M 728
2024
Q4
$5.27M Buy
+20,213
New +$6M 0.12% 130
2023
Q1
Sell
-8,529
Closed -$2.24M 601
2022
Q4
$2.24M Buy
+8,529
New +$2.29M 0.04% 387
2022
Q1
Sell
-2,942
Closed -$662K 1316
2021
Q4
$662K Buy
+2,942
New +$621K 0.01% 907
2021
Q3
Sell
-1,336
Closed -$326 1303
2021
Q2
$326 Sell
1,336
-9,649
-88% -$2.37M ﹤0.01% 1008
2021
Q1
$2.73M Buy
10,985
+3,195
+41% +$762K 0.03% 505
2020
Q4
$1.79M Buy
+7,790
New +$1.8M 0.03% 370
2018
Q4
Sell
-2,179
Closed -$452K 281
2018
Q3
$452K Buy
+2,179
New +$429K 0.01% 221
2018
Q1
Sell
-3,090
Closed -$537K 573
2017
Q4
$537K Buy
+3,090
New +$547K 0.01% 372
2017
Q2
Sell
-1,542
Closed -$253K 781
2017
Q1
$253K Buy
+1,542
New +$256K ﹤0.01% 623
2016
Q4
Sell
-3,782
Closed -$631K 30
2016
Q3
$631K Buy
+3,782
New +$640K 0.01% 324
2014
Q4
Sell
-8,635
Closed -$1.21M 177
2014
Q3
$1.21M Buy
+8,635
New +$1.13M 0.02% 171

Other funds holding AMGN

Magnetar Financial's AMGN Position: Q1 2025 in Review

Magnetar Financial sold out of Amgen (AMGN) in Q1 2025, closing a stake of 20,213 shares — an estimated $5.27M sold.

Magnetar Financial first reported a position in AMGN in Q3 2014 and held it in 11 quarters. The position peaked at $5.27M in Q4 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Magnetar Financial reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Magnetar Financial sold 20,213 Amgen shares in Q1 2025, an estimated $5.27M.
  • Magnetar Financial first reported a position in Amgen in Q3 2014 and held it in 11 quarters.
  • Magnetar Financial's Amgen position peaked at $5.27M in Q4 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.